Literature DB >> 25948839

Multidrug-resistant Nocardia pseudobrasiliensis presenting as multiple muscle abscesses.

Vimalkumar Veerappan Kandasamy1, Arun Nagabandi1, Edward A Horowitz2, Renuga Vivekanandan3.   

Abstract

A 79-year-old Caucasian man presented with multiple leg abscesses due to Nocardia pseudobrasiliensis. He was on chronic steroid therapy for myasthenia gravis. We present the difficulties in diagnosis and treatment of this rare organism. N. pseudobrasiliensis is a new emerging species that was previously thought to belong to the N. brasiliensis species. The distinction between the two species is extremely important given the different antibiotic susceptibility pattern and association of N. pseudobrasiliensis with more invasive and disseminated disease. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25948839      PMCID： PMC4434363          DOI： 10.1136/bcr-2014-205262

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  12 in total

1.  Disseminated Nocardia pseudobrasiliensis infection in a patient with AIDS in Brazil.

Authors:  B A Brown; J O Lopes; R W Wilson; J M Costa; A C de Vargas; S H Alves; C Klock; G O Onyi; R J Wallace
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

2.  Nocardia pseudobrasiliensis as an emerging cause of opportunistic infection after allogeneic hematopoietic stem cell transplantation.

Authors:  David Lebeaux; Fanny Lanternier; Nicolas Degand; Emilie Catherinot; Isabelle Podglajen; Marie-Thérèse Rubio; Felipe Suarez; Marc Lecuit; Jean-Luc Mainardi; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

Review 3.  Actinomycosis.

Authors:  R A Smego; G Foglia
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

Review 4.  Nocardiosis.

Authors:  P I Lerner
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

5.  List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet.

Authors:  J P Euzéby
Journal:  Int J Syst Bacteriol       Date:  1997-04

6.  Susceptibility testing of Nocardia species for the clinical laboratory.

Authors:  R J Wallace; L C Steele
Journal:  Diagn Microbiol Infect Dis       Date:  1988-03       Impact factor: 2.803

7.  First human case of nocardiosis caused by Nocardia pseudobrasiliensis in Japan.

Authors:  Akiko Kageyama; Hiroko Sato; Matsuo Nagata; Katsukiyo Yazawa; Masakazu Katsu; Yuzuru Mikami; Katsuhiko Kamei; Kazuko Nishimura
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

8.  Ventriculitis and choroid plexitis caused by multidrug-resistant Nocardia pseudobrasiliensis.

Authors:  Kanokporn Mongkolrattanothai; Sreemdevi Ramakrishnan; Michael Zagardo; Barry Gray
Journal:  Pediatr Infect Dis J       Date:  2008-07       Impact factor: 2.129

9.  Nocardia pseudobrasiliensis sp. nov., a new species of Nocardia which groups bacterial strains previously identified as Nocardia brasiliensis and associated with invasive diseases.

Authors:  R Ruimy; P Riegel; A Carlotti; P Boiron; G Bernardin; H Monteil; R J Wallace; R Christen
Journal:  Int J Syst Bacteriol       Date:  1996-01

10.  The first Korean case of disseminated mycetoma caused by Nocardia pseudobrasiliensis in a patient on long-term corticosteroid therapy for the treatment of microscopic polyangiitis.

Authors:  Chang-Ahn Seol; Heungsup Sung; Duck-Hee Kim; Misuk Ji; Yong-Pil Chong; Mi-Na Kim
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464
View more
  2 in total

1.  First Case of Nocardia pseudobrasiliensis Causing Primary Cutaneous Nocardiosis in an Immunocompetent Patient.

Authors:  Shraddhadevi Makadia; Ishan Patel; Ivan Soosaipillai; Aneta Tarasiuk-Rusek
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

2.  A case report of disseminated nocardiosis with ocular involvement in a myasthenia gravis patient and literature review.

Authors:  Shuhui Wang; Bin Jiang; Yao Li; Yanchang Shang; Zhengshan Liu; Yongbo Zhang
Journal:  BMC Neurol       Date:  2019-10-21       Impact factor: 2.474
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.